SCHEMBL11208992

SCHEMBL11208992

Cc1ccc2c([N+](=O)[O-])c(C)ccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.64
▸ ALDH1A1 P00352 4/20 0.54
▸ LMNA P02545 3/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ CYP3A4 P08684 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ HSP90AA1 P07900 2/20 0.47
▸ CRHBP P24387 2/20 0.47
▸ CRHR2 Q13324 2/20 0.47
▸ CYP1A2 P05177 3/20 0.44
▸ ESR1 P03372 1/20 0.43
▸ ESR2 Q92731 1/20 0.43
▸ CYP2A6 P11509 2/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ MITF O75030 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12294842 0.83 TSHR (0.60) TSHRALDH1A1LMNACYP3A4TDP1
SCHEMBL26933730 0.83 ESR1 (0.63) TSHRALDH1A1LMNAKDM4EGAA
SCHEMBL17263930 0.80 TSHR (0.64) TSHRALDH1A1HSD17B10CYP3A4TDP1
SCHEMBL8526914 0.79 TSHR (0.58) TSHRALDH1A1LMNAKDM4ECYP3A4
SCHEMBL1710125 0.78 TSHR (1.00) TSHRALDH1A1HSD17B10CYP3A4TDP1
SCHEMBL12433120 0.78 HPRT1 (0.56) TSHRALDH1A1CYP3A4TDP1HSP90AA1
SCHEMBL6142083 0.76 CYP3A4 (0.73) TSHRALDH1A1CYP3A4TDP1HSP90AA1
SCHEMBL12433122 0.75 PAX8 (0.48) ALDH1A1LMNAGAAHPGDCYP3A4
SCHEMBL24150001 0.74 TSHR (0.62) TSHRALDH1A1CYP3A4TDP1CYP1A2
SCHEMBL4427648 0.73 ALDH1A1 (0.71) TSHRALDH1A1HSD17B10CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180002346-A1 AZOLOBENZAZINE COMPOUNDS, COMPOSITIONS COMPRISING THESE COMPOUNDS AND THEIR USE FOR CONTROLLING INVERTEBRATE PESTS BASF SE (DE) 2018-01-04 — — US disclosed
EP-0023584-B1 PROCESS FOR THE PREPARATION OF TRIFLUOROMETHYL NAPHTHALENES BAYER AG (DE) 1983-01-26 — — EP disclosed
US-4331613-A Process for the preparation of trifluoromethylnaphthalenes BAYER AKTIENGESELLSCHAFT (DE) 1982-05-25 — — US disclosed
EP-0023584-A1 Process for the preparation of trifluoromethyl naphthalenes BAYER AG (DE) 1981-02-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002346-A1 AZOLOBENZAZINE COMPOUNDS, COMPOSITIONS COMPRISING THESE COMPOUNDS AND THEIR USE FOR CONTROLLING INVERTEBRATE PESTS DDT, CRY1, TH TSHR 4426/4885ALDH1A1 2080/4885LMNA 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback